3
Views
1
CrossRef citations to date
0
Altmetric
Invited communication

Intestinal failure in childhood

References

  • Goulet O, Sauvat F. Short bowel syndrome and intestinal transplantation in children. Curr Opin Clin Nutr Metab Care. 2006;9:304–13.
  • Colomb V, Dabbas-Tyan M, Taupin P, Talbotec C, Révillon Y, Jan D, De Potter S, Gorski-Colin AM, Lamor M, Herreman K, Corriol O, Landais P, Ricour C, Goulet O.Long-term outcome of children receiving home parenteral nutrition: a 20-year single-centre experience in 302 patients. J Pediatr Gastroenterol Nutr. 2007;44:347–53.
  • Goulet O, Ruemmele F. Causes and management of intestinal failure. Gastroenterology 2006;130:516–528.
  • Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology. 2003;124:1210–9.
  • David AI, Gaynor JJ, Zis PP, Conanan L, Goldsmith L, Esquenazi V, Selvaggi G, Weppler D, Nishida S, Moon J, Madariaga JR, Ruiz P, Kato T, Levi DM, Kleiner G, Tryphonopoulos P, Tzakis AG. An association of lower serum citrulline levels within 30 days of acute rejection in patients following small intestine transplantation. Transplant Proc. 2006;38:1731–2.
  • Jianfeng G, Weiming Z, Ning L, Fangnan L, Li T, Nan L, Jieshou L. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. J Surg Res. 2005;127:177–82.
  • Bailly-Botuha C, Colomb V, Thioulouse E, Berthe MC, Garcette K, Dubern B, Goulet O, Couderc R, Girardet JP. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res. 2009;65:559–63.
  • Koffeman GI, van Gemert WG, George EK, Veenendaal RA. Classification, epidemiology and aetiology. Best Pract Res Clin Gastroenterol. 2003;17:879–93.
  • Goulet O, Baglin-Gobet S, Talbotec C, Fourcade L, Colomb V, Sauvat F, Jais JP, Michel JL, Jan D, Ricour C.Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 2005;15:95–101.
  • Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005;40:755–762.
  • Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, Dicanzio J, Richardson DS, Collier SB, Lo C, Duggan C. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001;139:27–33.
  • Quiros-Tejeira RE, Ament ME, Reyen L, Herzog F, Merjanian M, Olivares-Serrano N, Vargas JH. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr. 2004;145:157–63.
  • Diamond IR, de Silva N, Pencharz PB, Kim JH, Wales PW. Group for the Improvement of Intestinal Function and Treatment. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg. 2007;42:806–11.
  • Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet. 2007;369:1614–20.
  • Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, Kuzma-O’Reilly B, Teitelbaum DH. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg. 2005;242:403–9; discussion 409–12.
  • Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil. 1999;11:141–61.
  • Jackson CS, Buchman AL. The nutritional management of short bowel syndrome. Nutr Clin Care. 2004;7:114–21.
  • Goulet O, Colomb-Jung V, Joly F. Role of the colon in short bowel syndrome and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2009;48 Suppl 2:S66–71.
  • Puwanant M, Mo-Suwan L, Patrapinyokul S. Recurrent D-lactic acidosis in a child with short bowel syndrome. Asia Pac J Clin Nutr. 2005;14:195–8.
  • Kaufman SS, Loseke CA, Lupo JV et al. Influence of bacterial overgrowth and intestinal inflammation on duration of PN in children with short bowel syndrome. J Pediatr 1997:131:356–361.
  • Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Dev Pediatr. 2003;50:245–67.
  • Matarese LE, Seidner DL, Steiger E. The role of probiotics in gastrointestinal disease. Nutr Clin Pract. 2003;18:507–16
  • Wales PW. Surgical therapy for short bowel syndrome. Pediatr Surg Int. 2004;20:647–57.
  • Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med 1997;90:429–32.
  • DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 2. Am J Gastroenterol. 2004;99:1823–32.
  • Javid PJ, Kim HB, Duggan CP, Jaksic T. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg. 2005;40:1019–23; discussion1023–4.
  • Modi BP, Javid PJ, Jaksic T, Piper H, Langer M, Duggan C, Kamin D, Kim HB; International STEP Data Registry. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg. 2007;204:365–71.
  • Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home PN-dependent short bowel patients: a positive study. Gastroenterology 2003;124:293–302.
  • Parekh NR, Steiger E. Criteria for the use of recombinant human growth hormone in short bowel syndrome. Nutr Clin Pract. 2005;20:503–8.
  • Dabbas-Tyan M, Colomb V, Rosilio M, Landais P, Ricour C, Goulet O. Evaluation of the effect of recombinant human growth hormone (rhGH) treatment of children with short bowel syndrome. J Pediatr Gastroenterol Nutr 2000;31:5165–5166
  • Lifschitz C, Duggan C, Lazngston C, Vanderhoof J, Shulman RJ. Growth Hormone (GH) therapy in children with short bowel syndrome (SBS): a randomized, placebo controlled study. Digestive Disease Week; Orlando 2003:A100.
  • Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005;54:1224–31.
  • Sigalet DL, Martin G, Meddings J, Hartman B, Holst JJ. GLP-2 levels in infants with intestinal dysfunction. Pediatr Res. 2004;56:371–6.
  • Iskit SH, Tugtepe H, Ayyildiz SH, Kotiloglu E, Dagli TE, Yegen BC. Epidermal growth factor and bombesin act synergistically to support intestinal adaptation in rats with massive small bowel resection. Pediatr Surg Int. 2005;21:436–40.
  • Sigalet DL, Martin GR, Butzner JD, Buret A, Meddings JB. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg. 2005;40:763–8
  • Sukhotnik I, Mogilner J, Shamir R, Shehadeh N, Bejar J, Hirsh M, Coran AG. Effect of subcutaneous insulin on intestinal adaptation in a rat model of short bowel syndrome.Pediatr Surg Int. 2005;21:132–7.
  • Sukhotnik I, Shehadeh N, Shamir R, Bejar J, Bernshten A, Mogilner JG. Oral enhances intestinal regrowth following massive resection in rat. Dig Dis Sci. 2005;50:2379–85.
  • Sauvat F, Grimaldi C, Lacaille F, Ruemmele F, Dupic L, Bourdaud N, Fusaro F, Colomb V, Jan D, Cezard JP, Aigrain Y, Revillon Y, Goulet O. Intestinal transplantation for total intestinal aganglionosis: a series of 12 consecutive children. J Pediatr Surg. 2008 ;43:1833–8.
  • Faure C, Goulet O, Ategbo S, Breton A, Tounian P, Ginies JL, et al. Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome and prognosis in 105 children. Dig Dis Scie 1999;44:953–959.
  • Loinaz C, Mittal N, Kato T, Miller B, Rodriguez M, Tzakis A. Multivisceral transplantation for pediatric intestinal pseudo-obstruction: single center’s experience of 16 cases. Transplant Proc. 2004;36:312–3.
  • Goulet O, Brousse N, Canioni D, et al Syndrome of intractable diarrhoea with persistent villous atrophy in early childhood : A clinicopatological survey of 47 cases. J Pediatr Gastroenterol Nutr 1998;26:151–161.
  • Ruemmele FM, Schmitz J, Goulet O. Microvillous inclusion disease (microvillous atrophy).Orphanet J Rare Dis. 2006;26:1:22.
  • Müller T, Hess MW, Schiefermeier N, et al. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity. Nat Genet. 2008;40:1163–5.
  • Goulet O, Sauvat F, Ruemmele F, Caldari D, Damotte D, Cezard JP, Lacaille F, Canioni D, Hugot JP, Berebi D, Sarnacki S, Colomb V, Jan D, Aigrain Y, Revillon Y. Results of the Paris program: ten years of pediatric intestinal transplantation. Transplant Proc 2005;37:1667–70.
  • Ruemmele F, Jan D, Lacaile F, Cezard JP, Canioni D, Phillips AD, Peuchmaur M, Aigrain Y, Brousse N, Schmitz J, Revillon Y, Goulet O. New perspectives for children with microvillous inclusion disease: early small bowel transplantation. Transplantation. 2004;77:1024–8.
  • Goulet O, Kedinger M, Brousse N, Cuenod B, Colomb V, Patey N, de Potter S, Mougenot JF, Canioni D, Cerf-Bensussan N. Intractable diarrhea of infancy: a new entity with epithelial and basement membrane abnormalities. J Pediatr 1995;127:212–9.
  • Goulet O, Salomon J, Ruemmele F, Patey-Mariaud de Serres N, Brousse N. Intestinal epithelial dysplasia (Tufting enteropathy). Orphanet J Rare Dis. 2007 20;2(1):20.
  • Sivagnanam M, Schaible T, Szigeti R, et al. Further evidence for EpCAM as the gene for congenital tufting enteropathy. Am J Med Genet A. 2010;152:222–4.
  • Ruemmele FM, Moes N, de Serre NP, Rieux-Laucat F, Goulet O.Clinical and molecular aspects of autoimmune enteropathy and immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked syndrome. Curr Opin Gastroenterol. 2008;24:742–8. .
  • Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome. J Med Genet 2002;39:537–45.
  • Bindl L, Torgerson T, Perroni L, Youssef N, Ochs HD, Goulet O, Ruemmele FM. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr. 2005;147:256–9.
  • Baud O, Goulet O, Canioni D, Le Deist F, Radford I, Rieu D, Dupuis-Girod S, Cerf-Bensussan N, Cavazzana-Calvo M, Brousse N, Fischer A, Casanova JL.Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, and X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001;344:1758–62.
  • Torgerson TR, Linane A, Moes N, Anover S, Mateo V, Rieux-Laucat F, Hermine O, Vijay S, Gambineri E, Cerf-Bensussan N, Fischer A, Ochs HD, Goulet O, Ruemmele FM. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene.. Gastroenterology. 2007;132:1705–17.
  • Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R; for the Parenteral Nutrition Guidelines Working Group. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005;41:S1–S4.
  • Botha JF, Grant WJ, Torres C, Iverson AK, Sudan DL, Shaw BW Jr, Langnas AN. Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome.Liver Transpl. 2006;12:1062–6.
  • Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 2007;44:459–63.
  • Pironi L, Hébuterne X, Van Gossum A, Messing B, Lyszkowska M, Colomb V, et al. .Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol 2006;101:1633–43.
  • American Gastroenterological Association medical position statement. short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124:115–1110
  • Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124:1111–34.
  • Kaufman SS, Atkinson JB, Bianchi A, Goulet OJ, Grant D, Langnas AN, McDiarmid SV, Mittal N, Reyes J, Tzakis AG; American Society of Transplantation. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transpl 2001;5:80–87.
  • Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term PN in children. J Parenter Enteral Nutr. 2000;24:345–50.
  • Goulet O, Joly F, Corriol O, Colomb-Jung V Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2009;14:256–61.
  • Bueno J, Ohwada S, Kocoshis S, Mazariegos GV, Dvorchik I, Sigurdsson L, Di Lorenzo C, Abu-Elmagd K, Reyes J.Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg 1999;34:27–33.
  • Fryer J, Pellar S, Ormond D, Koffron A, Abecassis M. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl. 2003;9:748–53.
  • Grant D, Abu-Elmagd K, Reyes J, Tzakis A, Langnas A, Fishbein T, Goulet O, Farmer D on the behalf of the Intestine Transplant Registry. 2003 report of the Intestine Transplant Registry: a new era has dawned. Ann Surg. 2005;241:607–13.
  • Sauvat F, Dupic L, Caldari D, Lesage F, Cézard JP, Lacaille F et al . Factors influencing outcome after intestinal transplantation in children. Transplant Proc. 2006;38:1689–91.
  • Lloyd DA, Vega R, Bassett P, Forbes A, Gabe SM. Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. Aliment Pharmacol Ther. 2006 15;24:1231–40.
  • Nucci A, Cartland Burns R, Armah T, Lowery K, Yaworski JA, Strohm S, Bond G, Mazariegos G, Squires R.. Interdisciplinary Management of Pediatric Intestinal Failure: A 10-Year Review of Rehabilitation and Transplantation. J Gastrointest Surg. 2008;12:429–436.
  • Sudan D. Cost and quality of life after intestinal transplantation. Gastroenterology. 2006;130:S132–7.
  • Lacaille F, Vass N, Sauvat F, Canioni D, Colomb V, Talbotec C, De Serre NP, Salomon J, Hugot JP, Cézard JP, Révillon Y, Ruemmele FM, Goulet O. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation. Gut. 2008;57:455–61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.